EID Parry Completes Acquisition of Valensa International
Producer of Astaxanthin, Premium Nutraceutical Ingredients & Formulations Poised for Growth
LAS VEGAS, Oct. 11, 2011 — E.I.D.-Parry (India) Limited, the bioproducts and nutraceutical division of the Murugappa Group, has announced the acquisition of 100% of the voting shares of U. S. Nut…
Vitamin B2 Eye Drops and Low Dose Ultraviolet May Cure Keratoconus
MCHENRY, Ill., March 29, 2011 — A potentially blinding disease called keratoconus may now be stopped and even reversed with a new process applying vitamin B2 eye drops and low-dose ultraviolet light to the diseased eye. The first FDA-monitored clinical trial in Illinois of what is called “…
Smart for Life(R) to Add Lepticore(R)
The Benefits of Lepticore Found in a Recent Study will Enhance the Smart for Life(R) Ingredient Base
BOCA RATON, Fla., Oct. 12, 2010 — Smart for Life(R), the trailblazing company featuring weight management products will begin adding Lepticore(R) to its product line this month. Lepticore(R) ha…
Advanced Targeting Systems, Inc. Announces $3 Million Award from National Cancer Institute
SAN DIEGO, Sept. 23, 2010 — Advanced Targeting Systems, the company that pioneered the targeting of specific cell types to manipulate them for the treatment of diseases and for research into the function of biological systems, has been awarded $3 million from the National Cancer Institute (NCI)…
Medical Skin Care Discovery Elevates Tattoo Healing
INKGUARD launches revolutionary new treatment product specifically for tattoos
NEW YORK, April 27, 2010 — TATTOO INKGUARD announces the United States retail debut of its FLUX AFTERCARE, a tattoo healing treatment.
FLUX AFTERCARE is the first-ever medical-grade treatment with years of devel…
PharmaCM CTR Express Provides Life Sciences Organizations With a Cost-Effective Solution Complete With All Workflows and Reports Necessary to Manage and Simplify Complex Disclosure Processes
NEW YORK, Feb. 9, 2010 — Intrasphere Technologies (http://www.intrasphere.com), a leading cons…
Significant Milestone Marks the Beginning of FDA-Authorized Breast Cancer Trial
Quantum Immunologics announces the completion of its first clinical treatment injection
TAMPA, Fla., July 13, 2009 — Quantum Immunologics, Inc. (QI), a Tampa, Florida company focusing on the research and development of cancer immunotherapies, announces that the first patient in its breast c…
Enhanced Functionality Empowers Users to Take Full Control of the Entire Clinical Trial Registration Process – from Assessment to Results Disclosure – while Adhering to Changing Regulatory Requirements; Two Top-Ten Pharmaceutical Companies Choose PharmaCM to Manage Their Clinical…
